tiprankstipranks
Trending News
More News >
NAVCO Pharmaceuticals Inc (TSE:NAV)
:NAV
Canadian Market

NAVCO Pharmaceuticals Inc (NAV) Income Statement

Compare
7 Followers

NAVCO Pharmaceuticals Inc Income Statement

Last quarter (Q4 2024), NAVCO Pharmaceuticals Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, NAVCO Pharmaceuticals Inc's net income was $-177.47K. See NAVCO Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ 31.59K$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 43.81K$ 10.66K$ 22.95K$ ―$ ―
EBITDA
$ -2.09M$ -3.33M$ -142.32K$ -74.08K$ -49.56K
Operating Income
$ -2.11M$ -3.34M$ -211.17K$ -79.54K$ -50.70K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -2.15M$ -3.34M$ -216.39K$ -74.08K$ -49.56K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

NAVCO Pharmaceuticals Inc Earnings and Revenue History